Funding Details
- Awarder
- Inbox
- Date Award
- January 06, 2021
- Vertical
- Synthetic Biology
- Funding URL
- View Funding Page
- Funding Amount:
-
$105,000,000
Company Info
- Founders
- Tim Lu, M.D., Ph.D.
- Company Description
- Senti Bio is a clinical-stage biotechnology company developing a new generation of cell and gene therapies for cancer.
- Market
- Therapeutics
- Location
-
South San Francisco,
California,
USA
- Coinvestors
- Amgen Business Development, Intel Capital, Leaps by Bayer, Lux Capital, Matrix Partners, Mirae Asset Venture Investment, New Enterprise Associates, Ridgeback Capital Management
Links